𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potentiality of vanadium compounds as anti-parasitic agents

✍ Scribed by Dinorah Gambino

Book ID
104011112
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
549 KB
Volume
255
Category
Article
ISSN
0010-8545

No coin nor oath required. For personal study only.

✦ Synopsis

Research efforts on the medicinal chemistry of vanadium have been mainly focused whether on improving biodistribution and tolerability of the vanadium insulin-enhancing core or on developing potential anti-tumor compounds. Despite the fact that the World Health Organization statistics show that parasitic diseases are among the most prevalent illnesses worldwide, work on vanadium compounds for the potential treatment of some of these diseases has only recently arisen. This review focuses on recent attempts to develop vanadium-based potential anti-parasitic agents, mainly active against the parasites causing American trypanosomiasis (Chagas disease), leishmaniasis and amoebiasis. In addition, the search for new therapeutic uses of some previously known bioactive vanadium compounds is included.

πŸ“œ SIMILAR VOLUMES

Hyperthermia: Potential as an anti-tumor
Hyperthermia: Potential as an anti-tumor agent
✍ Herman D. Suit; Michael Shwayder πŸ“‚ Article πŸ“… 1974 πŸ› John Wiley and Sons 🌐 English βš– 741 KB

Response of cells i n vitro a n d of intact tissue in vivo, both of normal a n d malignant origin, to moderate levels of hyperthermia has been reviewed. Abundant laboratory and clinical evidence exists which demonstrates that tolerable levels of hyperthermia (locally applied) can regularly effect a

Insulin-like actions of vanadium: Potent
Insulin-like actions of vanadium: Potential as a therapeutic agent
✍ Lucy Marzban; John H. McNeill πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

## Abstract Vanadium compounds are glucose‐lowering agents that are shown to mimic/enhance most of the metabolic actions of insulin both in vitro and in vivo. Several studies have demonstrated that vanadium treatment lowers plasma glucose levels in experimental models of type 1 diabetes and enhance